Persistent neuronal stress signalling underlies Angelman syndrome phenotypes

AI Insight

Researchers have identified that Angelman syndrome, a neurodevelopmental disorder, results from loss of the UBE3A ubiquitin ligase enzyme, which leads to excessive accumulation of asparagine synthetase protein in neurons. Through genetic and proteomic studies in both human neurons and mouse models, the team demonstrated that this protein overabundance is directly connected to the characteristic symptoms observed in Angelman syndrome patients. The findings reveal a specific molecular pathway linking the genetic cause to the clinical manifestations of the disorder.

Why it matters

This discovery provides a clear therapeutic target for Angelman syndrome by identifying asparagine synthetase as a key mediator of disease symptoms. The research opens possibilities for developing treatments that could reduce asparagine synthetase levels or activity, potentially alleviating symptoms in patients with this currently incurable condition.